One of the most interesting uses of blockchain that is being discussed at the moment has to do with the motivation of employees and business partners. Indeed, traditional systems of bonus systems and loyalty points have a very limited real-world use. By contrast, introducing of cryptographic tokens to reward successful distributors or team members could provide substantial value, serve as a serious motivation boost, and help scale a business.
A Russian-based company active in the health and wellness market, Alfa-Era Club, is taking the concept of tokenized motivation and scaling programs to a new level. Alfa-Era is ready to introduce distributed ledger-driven technology into the industry of franchising to scale the sales of its unique product.
Alfa-Era’s main area of activity is the distribution of condensed extract of alfalfa (also known as lucerne or Medicago sativa) – a highly active natural remedy. Alfalfa has been used in traditional Asian medicine for centuries, and multiple recent studies have confirmed its beneficial properties. Alfalfa has a strong antifungal and antimicrobial effect, especially against such microorganisms as Staphylococcus aureus, Candida albicans, Bacillus subtilis, Bacillus cereus, Corynebacterium diphtheriae, Escherichia coli, Proteus vulgaris, etc. Researchers are currently studying its potential users in the treatment and prevention of cancer, including melanoma, carcinoma, and breast cancer.
The alfalfa extract distributed by Alfa-Era is produced in the Russian republic of Bashkortostan (known for its under the trade-name of Eracond. Starting from the 60’s, alfalfa extract was studied and produced in the USSR due to its ability to suppress the effects of excessive radiation – an urgent issue in the times of the Cold War. Once it was discovered that lucerne extract also increases energy and stamina levels, it was prescribed to Soviet athletes. Wide use of Eracond in the USSR has coincided with the most important international successes of the Soviet team. At the same time, alfalfa extract was used as part of innovative cancer treatments. Eracond has been amply tested and served as the subject for several PhD dissertations.
At present, Alfa-Era has a successful distribution network, which it is planning to expand by issuing its own cryptographic token. The token is not designed to help raise funds for a new project – rather, it will serve as a base of a new motivation and rewards program for Alfa-Era’s franchisees, as well as to attract new distribution partners across the world.
The possibility to purchase the product for cryptocurrency will make Eracond accessible to potential distributors from across the world, bypassing the hurdles of international bank transfers. Any company in any country will be able to join the Alfa-Era franchise network. What’s more, franchising partners will be rewarded with tokens for hitting their sales objectives. Agents will also be able to use the tokens they receive to purchase additional supplies of Eracond or obtain discounts and special benefits.
Alfa-Era is planning to list the token at several major exchanges. This will provide trade agents and employees an even stronger motivation to perform well and earn more tokens, since they will be able to sell them at an exchange later with a profit. As the distribution network and the demand for the product grows, the token price is also expected to rise, giving a further spur to the scaling of the business.
The combination of easier entry into the network, better agent conditions, prospect of an additional gain, and unique features of the product itself will undoubtedly attract a large number of international agents to the Alfa-Era franchise. The owners of Alfalfa are certain that the distributed ledger technology has the potential to disrupt franchising networks across the world, providing agents and employees with real value. Further information can be obtained at https://www.eracond.ru/